ASCO 2013 - USACO

Chicago, IL - ASCO 2013 Annual Meeting: - Dr. Pascal Hammel presents his abstract "Comparison of chemoradiotherapy (CRT) and chemotherapy (ct) in patients with a locally advanced pancreatic ancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III" at the American Society for Clinical Oncology (ASCO) Annual Meeting here today, Monday June 3, 2013. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the McCormick Convention center and features the latest cancer research in the areas of basic and clinical science. Photo by © ASCO/Silas Crews 2013 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org

Comparison of chemoradiotherapy CRT and chemotherapy ct in patients with a locally advanced pancreatic ancer LAPC controlled after 4 months of gemcitabine with or without erlotinib Final results of the international phase III Dr. Pascal Hammel presents his abstract13asco1793